Clinsight AB

Clinsight is a spin out from Karolinska Institutet which are developing best in class precision medicine platform using artificial intelligence. Our mission is to improve reproducibility, accuracy and standardization of diagnosis and Gleason grading as well as predicting relapse & treatment response of prostate cancer. Our AI driven solutions are developed by world leading pathologists, researchers and AI experts in the field. The basis of our innovations has been published in Nature Communications, the Lancet and New England Journal of Medicine.